International Patent: PYRIMIDINYLAMINOBENZENES FOR TREATING CANCER WITH AN EGFR PACC MUTATION

GENEVA, Oct. 9 -- SUZHOU PUHE BIOPHARMA CO., LTD filed a patent application (CN2026/087865) for “PYRIMIDINYLAMINOBENZENES FOR TREATING CANCER WITH AN EGFR PACC MUTATION”. With publication no. WO/2026/208920, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/506

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....